Opportunity Information: Apply for RFA DA 24 022
This NIH funding opportunity (RFA-DA-24-022) supports a cooperative agreement (U24, clinical trial optional) to build a patient-centered research resource center aimed at advancing the federal Ending the HIV Epidemic effort for people who are involved in the criminal legal system. The central purpose is to create a Patient Engagement Resource Center (PERC) that strengthens and accelerates the work of the HIV/Justice Regional Research Hubs (referenced as being funded under RFA-DA-24-105) by supplying practical, scalable ways to bring the perspectives of affected communities directly into research planning and implementation. The emphasis is not just on producing research outputs, but on creating durable infrastructure, tools, and consultation capacity that multiple hub projects can use.
At the core of the project is a partnership model grounded in lived experience. The PERC is expected to collaborate with patients and other stakeholders who have direct experience with HIV, substance use disorders (SUD), and the criminal legal system. In practice, that means setting up a research advisory and consultation approach that can guide hub investigators on how to design studies, interventions, recruitment strategies, consent processes, retention plans, and dissemination activities in ways that are credible and usable for justice-involved populations. The opportunity highlights user-centered design as the overarching philosophy, signaling that the resource center should rely on structured feedback loops, co-design methods, and iterative testing rather than top-down program design.
Beyond consultation and engagement infrastructure, the awardee is also expected to carry out original research. That research component focuses on identifying major barriers that prevent justice-involved individuals from accessing and using HIV and SUD prevention and treatment services, and then pilot testing potential solutions to address those barriers. The intent is applied: identify what blocks care in real settings (during incarceration, at reentry, while on probation/parole, or in community supervision contexts) and test practical strategies that could improve uptake and continuity of HIV and SUD services. The combined center-and-research structure is meant to inform both research and practice, so findings and tools can be translated into how the hubs run their projects and, ideally, how systems deliver care.
Administratively, this is a discretionary NIH opportunity under CFDA 93.279, using a cooperative agreement mechanism, which typically means substantial NIH involvement in program stewardship compared to a standard grant. The listed award ceiling is $350,000, and the original closing date shown is August 16, 2023. While the opportunity references clinical trials as optional, applicants would still need to align any proposed human subjects activities with NIH policies and the specific requirements associated with U24 awards.
Eligibility is broad and includes many types of domestic organizations: state, county, and local governments; special districts; public housing authorities; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; other Native American tribal organizations; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other eligible entities. The announcement also calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, historically Black colleges and universities, tribally controlled colleges and universities, eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible; however, foreign components are allowed as defined under the NIH Grants Policy Statement, which generally means limited foreign involvement can be included when it is well-justified and compliant with NIH policy.
Overall, the grant is designed for an applicant that can function as a national-level support and coordination resource for multiple regional hub projects, while also generating new evidence about how to reduce real-world barriers to HIV and SUD services for people impacted by incarceration and related legal system involvement. The throughline is meaningful patient and lived-experience engagement, structured in a way that consistently improves how research and interventions are designed, tested, and ultimately adopted in justice-related settings.Apply for RFA DA 24 022
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2023-04-19.
- Applicants must submit their applications by 2023-08-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $350,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH RFA-DA-24-022 Patient Engagement Resource Center (PERC)
What is this funding opportunity (RFA-DA-24-022) about?
This NIH funding opportunity supports a cooperative agreement (U24, clinical trial optional) to build a Patient Engagement Resource Center (PERC) focused on advancing the federal Ending the HIV Epidemic effort for people involved in the criminal legal system. The main aim is to create practical, scalable engagement infrastructure that helps ensure research is designed and carried out in ways that reflect the needs and realities of justice-involved populations.
What is the PERC expected to do?
The PERC is expected to function as a patient-centered support and coordination resource. It should supply tools, infrastructure, and consultation capacity that can be used across multiple projects, especially the HIV/Justice Regional Research Hubs referenced as funded under RFA-DA-24-105. The focus is on durable resources and processes that improve how research is planned, implemented, and shared.
How does this opportunity relate to the HIV/Justice Regional Research Hubs?
The PERC is intended to strengthen and accelerate the work of the HIV/Justice Regional Research Hubs by providing practical ways to incorporate the perspectives of affected communities into hub research planning and implementation. In other words, the PERC supports the hubs by offering engagement methods, consultation, and reusable resources that hub investigators can apply across multiple studies and settings.
Is the emphasis on producing research outputs or building infrastructure?
The emphasis is not only on traditional research outputs. A central expectation is building durable infrastructure, tools, and consultation capacity that multiple hub projects can reuse. The intent is to create practical, scalable resources that improve real-world research design and delivery for justice-involved populations.
What does "patient-centered" mean in the context of this opportunity?
Patient-centered here means grounding the resource center in lived experience and ensuring that people directly affected by HIV, substance use disorders (SUD), and the criminal legal system meaningfully shape how research is designed and carried out. This includes incorporating community perspectives into recruitment, consent, retention, intervention design, and dissemination in ways that are credible and usable for justice-involved populations.
Who are the key stakeholders the PERC should partner with?
The PERC is expected to collaborate with patients and other stakeholders who have direct experience with HIV, SUD, and the criminal legal system. The partnership model is explicitly grounded in lived experience to ensure research approaches fit real settings and real constraints.
What kind of engagement and consultation activities are expected?
The opportunity describes a research advisory and consultation approach that helps guide hub investigators on practical matters such as study and intervention design, recruitment strategies, consent processes, retention plans, and dissemination activities. The goal is to help investigators design research that is workable, trusted, and relevant for justice-involved communities.
What is meant by "user-centered design" in this announcement?
User-centered design is described as an overarching philosophy for the PERC. It suggests the center should rely on structured feedback loops, co-design methods, and iterative testing rather than top-down program design. The idea is to build tools and processes with the people who will be affected by and use them, refining approaches based on real feedback.
Does the award require the PERC to conduct original research?
Yes. Beyond engagement infrastructure and consultation support, the awardee is also expected to carry out original research aimed at identifying major barriers that prevent justice-involved individuals from accessing and using HIV and SUD prevention and treatment services, and then pilot testing potential solutions to address those barriers.
What is the focus of the research component?
The research is applied and focuses on real-world barriers that block access to HIV and SUD prevention and treatment. It also involves pilot testing strategies intended to improve uptake and continuity of services across settings such as during incarceration, at reentry, or within probation/parole and community supervision contexts.
Which settings and points of contact are highlighted for understanding barriers to care?
The opportunity highlights several real-world contexts where barriers may occur: during incarceration, at reentry, while on probation or parole, and in community supervision contexts. The intent is to identify what blocks care across these touchpoints and test practical strategies to improve continuity and service use.
How are the tools and findings expected to be used?
The combined center-and-research structure is meant to inform both research and practice. The expectation is that tools, consultation approaches, and research findings can be translated into how the hubs run their projects and, ideally, how systems deliver HIV and SUD services for justice-involved individuals.
What funding mechanism is being used?
This opportunity uses a cooperative agreement mechanism (U24). Cooperative agreements typically involve substantial NIH involvement in program stewardship compared to a standard grant.
Are clinical trials allowed under this opportunity?
Clinical trials are described as optional. Applicants would still need to ensure any proposed human subjects activities align with NIH policies and the specific requirements associated with U24 awards.
What is the award ceiling for this opportunity?
The listed award ceiling is $350,000.
What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.279.
What is the closing date listed for this opportunity?
The original closing date shown is August 16, 2023.
Who is eligible to apply?
Eligibility is broad and includes many types of domestic organizations, including state, county, and local governments; special districts; public housing authorities; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses); small businesses; and other eligible entities.
Are there specific categories of institutions and organizations called out as eligible?
Yes. The announcement also specifically calls out Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, historically Black colleges and universities, tribally controlled colleges and universities, eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible to apply.
Can a U.S. organization include a non-U.S. component on the application?
No. Non-U.S. components of U.S. organizations are not eligible.
Are foreign components allowed at all?
Foreign components are allowed as defined under the NIH Grants Policy Statement. This generally means limited foreign involvement can be included when it is well-justified and compliant with NIH policy, even though foreign institutions and non-U.S. components are not eligible to apply.
What kind of applicant is this opportunity designed for?
The grant is designed for an applicant that can function as a national-level support and coordination resource for multiple regional hub projects, while also generating new evidence about reducing barriers to HIV and SUD services for people impacted by incarceration and related legal system involvement.
What is the central "throughline" of the opportunity?
The central throughline is meaningful patient and lived-experience engagement, structured to consistently improve how research and interventions are designed, tested, and shared in justice-related settings.
Browse more opportunities from the same category: Education, Health
Next opportunity: Limited Competition: The Harmonized Cognitive Assessment Protocol (HCAP) Network (U24 Clinical Trial Not Allowed)
Previous opportunity: 1890 Facilities Grants Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 24 022
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 24 022) also looked into and applied for these:
| Funding Opportunity |
|---|
| Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required) Apply for RFA DA 24 015 Funding Number: RFA DA 24 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional) Apply for RFA DA 24 023 Funding Number: RFA DA 24 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed) Apply for RFA CA 23 029 Funding Number: RFA CA 23 029 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 24 005 Funding Number: RFA CA 24 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 23 034 Funding Number: RFA CA 23 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 23 035 Funding Number: RFA CA 23 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed) Apply for RFA CA 23 038 Funding Number: RFA CA 23 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed) Apply for RFA DA 24 019 Funding Number: RFA DA 24 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional) Apply for RFA DA 24 016 Funding Number: RFA DA 24 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed) Apply for RFA DA 24 028 Funding Number: RFA DA 24 028 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) Apply for RFA DA 24 024 Funding Number: RFA DA 24 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required) Apply for RFA DA 24 029 Funding Number: RFA DA 24 029 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed) Apply for PAR 23 151 Funding Number: PAR 23 151 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) Apply for PAR 23 183 Funding Number: PAR 23 183 Agency: National Institutes of Health Category: Education, Health Funding Amount: $75,000 |
| Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional) Apply for RFA DA 24 018 Funding Number: RFA DA 24 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: $295,924 |
| Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional) Apply for RFA DA 24 017 Funding Number: RFA DA 24 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: $295,924 |
| Accelerating Behavioral and Social Science through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed) Apply for PAR 23 182 Funding Number: PAR 23 182 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 024 Funding Number: RFA CA 23 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) Apply for RFA HG 23 017 Funding Number: RFA HG 23 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional) Apply for RFA AG 24 025 Funding Number: RFA AG 24 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 24 022", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.